Stockholders' Equity - Narrative (Detail)				1 Months Ended	9 Months Ended
	Apr. 03, 2023 USD ($)	Feb. 28, 2023 USD ($) $ / shares	Aug. 03, 2022 USD ($) $ / shares	Feb. 28, 2022 alternative	Sep. 30, 2023 USD ($) agreement $ / shares shares	Sep. 30, 2022 USD ($) agreement shares	Dec. 31, 2022 agreement shares	Nov. 30, 2022 USD ($)	Oct. 31, 2020 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Sale of stock, number of shares authorized (in shares) | shares							458,459
Expected proceeds from sale of stock		$ 301,600,000
Expected issuance of common stock, weighted average price (in dollars per share) | $ / shares		$ 657.75
Proceeds from redeemable non-controlling interest	$ 25,000,000				$ 25,000,000	$ 0
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock units, approved (in shares) | shares					943,224
Weighted-average grant date fair value (in dollars per share) | $ / shares					$ 694.34
Requisite service period (in years)					3 years 6 months 7 days
2020 ATM Program
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Sale of stock, equity offering agreement, authorized									$ 1,500,000,000
Sale of stock, number of shares authorized (in shares) | shares					308,875		0
2022 ATM Program
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Sale of stock, equity offering agreement, authorized								$ 1,500,000,000
Number of settlement alternatives | alternative				3
Sale of stock, number of shares authorized (in shares) | shares					149,584
Sale of stock, equity offering agreement, available for sale					$ 1,000,000,000
Equity Forward Amendment
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of forward sale agreements | agreement					5	5	3
Issuance of common stock, shares sold (in shares) | shares					564,126	579,873
Gross proceeds from sale of stock			$ 393,600,000
Issuance of common stock, weighted average price (in dollars per share) | $ / shares			$ 678.72		$ 764.78
Expected proceeds from sale of stock					$ 431,400,000
Equity Forward Amendment Second Sale
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of common stock, shares sold (in shares) | shares						580,833
Gross proceeds from sale of stock						$ 403,600,000